![Karin Eklund Vanderpol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Eklund Vanderpol
General Counsel bei
VICORE PHARMA HOLDING AB
Profil
Karin Eklund Vanderpol is currently Vice President-Regulatory Affairs at Vicore Pharma Holding AB since 2022.
Former positions include Director-Global Regulatory Affairs at Swedish Orphan Biovitrum AB, Head-Regulatory Affairs at AstraZeneca AB, and Head-Regulatory Affairs at Oncopeptides AB from 2020 to 2022.
Education includes a graduate degree from the University of Uppsala.
Aktive Positionen von Karin Eklund Vanderpol
| Unternehmen | Position | Beginn |
|---|---|---|
| VICORE PHARMA HOLDING AB | General Counsel | 01.01.2022 |
Ehemalige bekannte Positionen von Karin Eklund Vanderpol
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOPEPTIDES AB | General Counsel | 01.01.2022 |
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | 01.12.2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | General Counsel | - |
Ausbildung von Karin Eklund Vanderpol
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
7
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
